Abstract:
New thiosemicarbazones based on 5-arylisoxazole-3-carbaldehyde and substituted pyrrolecarbaldehydes have been obtained. The test for ability to inhibit the main viral protease 3Clpro of SARS-CoV-2 virus revealed a compound with activity against both corona- and influenza viruses.
Citation:
O. A. Zhupikova, O. I. Yarovaya, M. K. Marenina, Yu. V. Meshkova, S. V. Belenkaya, D. N. Shcherbakov, A. V. Zaykovskaya, O. V. Pyankov, V. V. Zarubaev, M. G. Mikhalsky, A. Yu. Fedorov, S. G. Arkhipov, V. I. Potkin, I. A. Kolesnik, A. V. Ivanov, N. F. Salakhutdinov, M. V. Khvostov, “New thiosemicarbazones possessing activity against SARS-CoV-2 and H1N1 influenza viruses”, Mendeleev Commun., 35:2 (2025), 145–147